<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet2008124-29</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-6841</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Ингибитор фосфодиэстеразы 5 типа (Левитра): возможности коррекции эректильной дисфункции у больных ожирением</article-title><trans-title-group xml:lang="en"><trans-title>Phosphodiesterase type 5 inhibitor (Levitra): possibility of correction of erectile dysfunction in obese patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Popova</surname><given-names>A Yu</given-names></name></name-alternatives><bio xml:lang="ru"><p>ГОУ ДПО Российская медицинская академия последипломного образования «Росздрава»</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Kondrat'eva</surname><given-names>L V</given-names></name></name-alternatives><bio xml:lang="ru"><p>ГОУ ДПО Российская медицинская академия последипломного образования «Росздрава»</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ametov</surname><given-names>A S</given-names></name></name-alternatives><bio xml:lang="ru"><p>ГОУ ДПО Российская медицинская академия последипломного образования «Росздрава»</p></bio><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>15</day><month>03</month><year>2008</year></pub-date><volume>5</volume><issue>1</issue><issue-title>№1 (2008)</issue-title><fpage>24</fpage><lpage>29</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Popova A.Y., Kondrat'eva L.V., Ametov A.S., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Popova A.Y., Kondrat'eva L.V., Ametov A.S.</copyright-holder><copyright-holder xml:lang="en">Popova A.Y., Kondrat'eva L.V., Ametov A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/6841">https://www.omet-endojournals.ru/jour/article/view/6841</self-uri><abstract><p>Ожирение является причиной развития целого ряда заболеваний, таких, как сахарный диабет 2 типа, артериальная гипертензия,атеросклероз и ишемическая болезнь сердца [<xref ref-type="bibr" rid="cit1">1</xref>]. С ожирением связывают развитие ряда гормонально зависимых злокачественных опухолей (рак молочной железы, рак матки), а также рак толстой кишки [<xref ref-type="bibr" rid="cit2">2</xref>]. Метаболические и гормональные нарушения, сопровождающие ожирение и лежащие в основе целого ряда заболеваний, могут в том числе оказывать влияние и на эректильную функцию. Несмотря на то что в литературе встречаются отдельные публикации, посвященные взаимосвязи ожирения и эректильной дисфункции (ЭД), нам не удалось обнаружить работ, посвященных эффективности лечения больных с эректильной дисфункцией и ожирением. Данные крупномасштабных научных исследований, посвященных роли снижения массы тела в лечении других заболеваний, в частности таких, как сахарный диабет 2 типа, артериальная гипертензия, ишемическая болезнь сердца, дают основание полагать, что контроль массы тела и сопутствующих метаболических нарушений способны обеспечить значительное улучшение качества эректильной функции и эффективность лечения ЭД [3, 4, 5, 6].</p></abstract><trans-abstract xml:lang="en"><p>Obesity is the cause of a number of diseases such as type 2 diabetes, hypertension, atherosclerosis and coronary heart disease [<xref ref-type="bibr" rid="cit1">1</xref>]. Obesity is associated with the development of a number of hormone-dependent tumors (breast cancer, uterine cancer) and colon cancer [<xref ref-type="bibr" rid="cit2">2</xref>]. Metabolic and hormonal disorders that accompany obesity and underlying a number of diseases, including may have an impact on erectile function. Despite the fact that in the literature there are few publications on the relationship of obesity and erectile dysfunction (ED), we could not find work on the effectiveness of treatment of patients with erectile dysfunction and obesity. These large-scale research on the role of weight loss in the treatment of other diseases, such as such as type 2 diabetes, hypertension, coronary heart disease, suggest that weight control and related metabolic disorders are able to provide a significant improvement in erectile quality function and effectiveness of the treatment of ED [3, 4, 5, 6].</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. // РМЖ 2001. - Т.9. - №2. - С.56.</mixed-citation><mixed-citation xml:lang="en">Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. // РМЖ 2001. - Т.9. - №2. - С.56.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Puska P., Nishida C., Porter D. Global strategy on diet, diet, physical activity and health. Obesity and overweight. WHO 2003</mixed-citation><mixed-citation xml:lang="en">Puska P., Nishida C., Porter D. Global strategy on diet, diet, physical activity and health. Obesity and overweight. WHO 2003</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003 Aug 5;139(3):161-8.</mixed-citation><mixed-citation xml:lang="en">Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003 Aug 5;139(3):161-8.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shiri R, Koskimaki J, Hakama M, Hakkinen J, Huhtala H, Tammela TL, Auvinen A. Effect of life-style factors on incidence of erectile dysfunction. Int J Impot Res. 2004 Oct;16(5):389-94.</mixed-citation><mixed-citation xml:lang="en">Shiri R, Koskimaki J, Hakama M, Hakkinen J, Huhtala H, Tammela TL, Auvinen A. Effect of life-style factors on incidence of erectile dysfunction. Int J Impot Res. 2004 Oct;16(5):389-94.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Israilov S, Baniel J, Shmueli J, Niv E, Engelstein D, Segenreich E, Livne PM. Treatment program for erectile dysfunction in patients with cardiovascular dis- eases. Am J Cardiol. 2004 Mar 15;93(6):689-93</mixed-citation><mixed-citation xml:lang="en">Israilov S, Baniel J, Shmueli J, Niv E, Engelstein D, Segenreich E, Livne PM. Treatment program for erectile dysfunction in patients with cardiovascular dis- eases. Am J Cardiol. 2004 Mar 15;93(6):689-93</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Israilov S, Shmuely J, Niv E, Engelstein D, Livne P, Boniel J. Evaluation of a pro- gressive treatment program for erectile dysfunction in patients with diabetes mel- litus. Int J Impot Res. 2005 May 12; [Epub ahead of print]</mixed-citation><mixed-citation xml:lang="en">Israilov S, Shmuely J, Niv E, Engelstein D, Livne P, Boniel J. Evaluation of a pro- gressive treatment program for erectile dysfunction in patients with diabetes mel- litus. Int J Impot Res. 2005 May 12; [Epub ahead of print]</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
